跳至主要内容
临床试验/NCT03778463
NCT03778463Unknown不适用

Synovectomy Versus no Synovectomy in Primary Total Knee Arthrplasty : A Randomized Control Trial

Ain Shams University2 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2018年12月最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
70
试验地点
2
主要终点
Health related quality of life e.g. short form (SF12) scale

研究概览

简要总结

The aim of total knee arthroplasty is to achieve best patient functional outcomes, improve patient pain score and satisfaction. Synovial proliferation is a common finding in arthritic knees. Surgeons can't decide if synovectomy is a crucial step in the operation. Studies didn't prove the clear benefits of synovectomy. We are aiming to perform a randomized clinical trial trying to reach the best evidence in that matter.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

性别
All
接受健康志愿者

入选标准

  • patients with primary osteoarthritis undergoing primary total knee arthroplasty

排除标准

  • Inflammatory arthritis
  • Revision knee arthroplasty

研究组 & 干预措施

Synovectomy

Experimental

干预措施: Synovectomy (Other)

No synovectomy

No Intervention

结局指标

主要结局

Health related quality of life e.g. short form (SF12) scale

时间窗: one year

Reoperation rate

时间窗: one year

Range of motion

时间窗: One year

knee pain e.g. visual analogue score (VAS) score

时间窗: immediate postoperative

Functional outcome scores. e.g. knee society score (KSS)

时间窗: one year

Revision rate

时间窗: one year

次要结局

  • Wound complications(in first 3 months)
  • Postoperative hemoglobin level(immediate postoperative)
  • Postoperative blood loss(immediate postoperative)
  • Number of patients requiring transfusion(immediate postoperative)
  • Infection rate(in first three month)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmed Saeed Younis

Principle investigator

Ain Shams University

研究点 (2)

Loading locations...

相似试验